Induction of multiple myeloma-specific cytotoxic T lymphocyte stimulation by dendritic cell pulsing with purified and optimized myeloma cell lysates.
about
Dendritic Cell-Based Cancer Immunotherapy against Multiple Myeloma: From Bench to ClinicRecent advances in multiple myeloma: a Korean perspectiveAlpha-Type 1 Polarized Dendritic Cells Loaded with Apoptotic Allogeneic Breast Cancer Cells Can Induce Potent Cytotoxic T Lymphocytes against Breast Cancer.Immunotherapy using dendritic cells against multiple myeloma: how to improve?Cellular immunotherapy using dendritic cells against multiple myelomaChimeric NKG2D receptor-expressing T cells as an immunotherapy for multiple myelomaImmune oppression array elucidating immune escape and survival mechanisms in uveal melanoma.Optimal culture conditions for the generation of natural killer cell-induced dendritic cells for cancer immunotherapy.Drug-mediated and cellular immunotherapy in multiple myeloma.Novel strategies for immunotherapy in multiple myeloma: previous experience and future directions.Evolution of cellular immunotherapy: from allogeneic transplant to dendritic cell vaccination as treatment for multiple myeloma.Immunotherapy for multiple myeloma.Immunotherapy for Multiple Myeloma, Past, Present, and Future: Monoclonal Antibodies, Vaccines, and Cellular Therapies.Generation of potent cytotoxic T lymphocytes against castration-resistant prostate cancer cells by dendritic cells loaded with dying allogeneic prostate cancer cells.Novel epitope evoking CD138 antigen-specific cytotoxic T lymphocytes targeting multiple myeloma and other plasma cell disorders.Identification of novel myeloma-specific XBP1 peptides able to generate cytotoxic T lymphocytes: a potential therapeutic application in multiple myeloma.Dendritic cell cancer vaccines: from the bench to the bedside.Plasma cell lysate as an antigen source in multiple myeloma immunotherapy.Identification and characterization of HLA-A24-specific XBP1, CD138 (Syndecan-1) and CS1 (SLAMF7) peptides inducing antigens-specific memory cytotoxic T lymphocytes targeting multiple myeloma.
P2860
Q27023621-F1B3C3DC-614A-46F5-81D5-2E3CF0C041D6Q28074521-1C520097-1F86-4D22-B9D9-4122C161ED65Q34771278-66369A5E-657B-4136-B0C0-49C7BC822185Q35852574-A10E2C22-86D8-4D1A-B806-9B8A81227F53Q35865581-650E6F28-DEE6-4329-B54B-217D1275831DQ37089674-7B93B576-291C-4015-AA66-5513D2C1ACF4Q37500476-F9D99A2F-EBE6-43B5-A041-7B91F5E057B4Q37729135-6FA99336-240D-4E6F-A029-5C90351161B0Q37773257-0944DDB0-1EF3-4133-81B1-3A8692EF5D8CQ38014834-1AEE41DC-B6A3-4F89-9CD4-4B8FB33E52C9Q38059517-D3AD0CDC-2613-418C-9471-F3CD1AFCFEC9Q38177879-84C7206F-10FB-458F-AFB9-F0A0492D1570Q38580545-089DC7AD-B4E2-406F-9344-7A2C6508C2A6Q39249471-0B679E64-C048-4C4E-BFDF-92CC7279A633Q39477274-2BDA42C0-FBF2-4DB4-91F8-AE7B8DE97156Q39527323-B431738D-140D-4BAC-B0CC-B296D9ADF56AQ42979673-9F08A7A0-B6B5-4CE8-B02C-F91B547FF6EBQ46965120-A496C768-6EE9-4EFF-AC97-ACD17E2DBDD8Q47580433-2FF3A3BB-4E25-41E2-A68F-42AE4ECB4B88
P2860
Induction of multiple myeloma-specific cytotoxic T lymphocyte stimulation by dendritic cell pulsing with purified and optimized myeloma cell lysates.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Induction of multiple myeloma- ...... ptimized myeloma cell lysates.
@en
Induction of multiple myeloma- ...... ptimized myeloma cell lysates.
@nl
type
label
Induction of multiple myeloma- ...... ptimized myeloma cell lysates.
@en
Induction of multiple myeloma- ...... ptimized myeloma cell lysates.
@nl
prefLabel
Induction of multiple myeloma- ...... ptimized myeloma cell lysates.
@en
Induction of multiple myeloma- ...... ptimized myeloma cell lysates.
@nl
P2093
P2860
P1433
P1476
Induction of multiple myeloma- ...... ptimized myeloma cell lysates.
@en
P2093
Bo-Hwa Choi
Deok-Hwan Yang
Hyeoung-Joon Kim
Hyun-Kyu Kang
Ik-Joo Chung
Je-Jung Lee
Jong-Hee Nam
Joon-Haeng Rhee
Jung-Sun Park
P2860
P304
P356
10.1080/10428190701583975
P577
2007-10-01T00:00:00Z